-

Global Robotic Process Automation (RPA) Thematic Research Report 2022: Market will be Valued at $20.1 Billion in 2030, up from $4.8 Billion in 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Robotic Process Automation - Thematic Research" report has been added to ResearchAndMarkets.com's offering.

Global RPA software and services market will be worth $20.1 billion in 2030, up from $4.8 billion in 2021.

Robotic process automation (RPA) describes software that can be programmed to perform basic tasks across a range of platforms and applications. Businesses in virtually every industry accelerated their automation efforts during the pandemic. For some, RPA allowed them to reimagine how they work, while others used RPA to ensure business continued as usual.

RPA is not a technology for a dystopian future; it is here and has attracted the attention of leaders and executives. The time for investing in RPA was yesterday.

Key Highlights

  • COVID-19 highlighted the necessity of coordinating automation across a business. This has accelerated the development of RPA as companies move away from stand-alone automation capabilities and offer RPA as part of a broader toolkit of automation and artificial intelligence (AI) technologies, allowing for end-to-end automation of more complex business processes.
  • RPA has evolved into intelligent automation, wherein AI and other business process technologies-such as low-code development tools, process mining, intelligent document processing, and business process management (BPM)-are combined with RPA to facilitate enterprise-wide automation initiatives.

Scope

  • This report provides an overview of the robotic process automation (RPA) theme.
  • It identifies the key trends impacting growth of the theme over the next 12 to 24 months, split into three categories: technology trends, macroeconomic trends, and regulatory trends.
  • It includes comprehensive industry analysis, including global market forecasts for RPA and analysis of patents, company filings, hiring, and social media trends.
  • It contains details of M&A deals driven by the RPA theme, and a timeline highlighting milestones in the development of RPA.
  • The detailed value chain is split into three main areas: process discovery, software, and services.

Reasons to Buy

  • COVID-19 increased interest in RPA as enterprises sought to reduce dependency on a human workforce for routine, digital processes and safeguard against future disruptions. RPA is a relatively fast technology solution to implement and constitutes a quick way for enterprises to make headway on their digital transformation efforts. The rapid shift to a digital workforce induced by the pandemic will drive market growth through 2025.
  • This report provides an invaluable guide to this disruptive theme. It includes comprehensive lists of the leading players across all aspects of the RPA value chain, helping companies identify the right partners.

Key Topics Covered:

  • Executive Summary
  • Players
  • Technology Briefing
  • Trends
  • Technology trends
  • Macroeconomic trends
  • Regulatory trends
  • Industry Analysis
  • Market size and growth forecasts
  • Mergers and acquisitions
  • Patent trends
  • Company filings trends
  • Hiring trends
  • Social media trends
  • Use cases
  • Timeline
  • Value Chain
  • Process discovery
  • RPA software
  • RPA services
  • Companies
  • Process discovery
  • RPA-centric platforms
  • Embedded RPA
  • RPA services
  • Sector Scorecards
  • Application software sector scorecard
  • Cloud services sector scorecard
  • IT services sector scorecard
  • Glossary

Companies Mentioned

  • UiPath
  • Automation Anywhere
  • SS&C Blue Prism
  • WorkFusion
  • NICE
  • Microsoft
  • Salesforce
  • ServiceNow
  • Appian
  • Pega
  • Kofax
  • Nintex
  • Celonis
  • Abbyy
  • Software AG
  • IBM
  • Accenture
  • Capgemini
  • Deloitte
  • Cognizant
  • TCS
  • Infosys
  • Wipro
  • SAP

For more information about this report visit https://www.researchandmarkets.com/r/xotnlp

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Sysmex Corp (6869) Product Pipeline Analysis Report 2025: Haematology, Haemostasis, and Urinalysis Analyzers - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Sysmex Corp (6869) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Sysmex Corp (Sysmex) is a provider of medical devices that researches, develops, manufactures and sells instruments, reagents, and s...

Ypsomed Holding AG (YPSN) Product Pipeline Analysis Report 2025: Self-Injection and Infusion Systems Portfolio - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ypsomed Holding AG (YPSN) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops, and manufactures injection and infusion syste...

Cochlear Ltd (COH) Product Pipeline Analysis Report 2025: Portfolio Includes Cochlear Implants, Bone Conduction Systems, Acoustic Implants, and Wireless Accessories - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cochlear Ltd (COH) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to customers. It develops, manufacture...
Back to Newsroom